Being ignored by the market at this point might just be a positive. Finishing CRUISE-1 patient dosing on time is only a news worthy event to long time followers of RMTI who know the is the first time Chioni has actually completed a trial on time. Maybe all those millions he's been spending actually went to good use.
I think most folks holding this stock now are in it through the CRUISE-1 readout And frankly, the smart shorts who walked this stock down from $9+ are likely scaling out of their positions now.
Lets see if we get a nice quiet creap up in the stock price into the July data release.